Status:
COMPLETED
Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)
Lead Sponsor:
Allergan
Conditions:
Glaucoma
Eligibility:
All Genders
Brief Summary
A retrospective, non-interventional, observational, multi-center, chart review study to be conducted in participants who underwent placement of the XEN 45 Gel Stent as a standalone procedure or in com...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Eye treated with XEN 45 Gel Stent for primary open angle glaucoma as a standalone procedure or in combination with phacoemulsification
- XEN 45 Gel Stent was implanted between 1 January 2014 and 1 October 2015
- Exclusion Criteria
- None
Exclusion
Key Trial Info
Start Date :
April 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 25 2019
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT03868254
Start Date
April 5 2019
End Date
October 25 2019
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trials Registry Team
Irvine, California, United States, 92622